Browsing: Therapy

An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). MOGAD is a rare autoimmune neurological disorder that can cause vision loss, paralysis and other serious neurological complications

A pilot trial with 12 US veterans with post-traumatic stress disorder (PTSD) showed that psilocybin — the active ingredient in magic mushrooms — eased the symptoms for 75% of the participants after one month. Their remaining symptoms no longer met the criteria to be classified as PTSD. 

Cell therapies are growing in variety and effectiveness across many diseases. In the fight against Duchenne muscular dystrophy (DMD), deramiocel has emerged as an effective treatment for DMD in patients in early clinical trials. New data from the HOPE-3 Phase III clinical trial, published inThe Lancet, expand the efficacy to include patients with advanced DMD